CITADEL ADVISORS LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares")
Symbol
LXEO
Shares outstanding
55,563,667 shares
Disclosed Ownership
5,334,112 shares
Ownership
9.6%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:58:22 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 9.6% 5,325,269 0 5,325,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 9.6% 5,325,269 0 5,325,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 9.6% 5,325,269 0 5,325,269 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 8,843 0 8,843 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0% 8,843 0 8,843 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0% 8,843 0 8,843 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 9.6% 5,334,112 0 5,334,112 /s/ Seth Levy Seth Levy, attorney-in-fact*